We are live on
!
Find out more
BCM
Bayesian Capital Management Portfolio holdings
AUM
$81.9M
1-Year Est. Return
26.59%
This Fund
S&P 500
This Quarter
Est. Return
-3.38%
1 Year Est. Return
+26.59%
3 Year Est. Return
+112.98%
5 Year Est. Return
+129.77%
10 Year Est. Return
+1,146.62%
AUM
$43.6M
AUM Growth
-$446M
(-91%)
Cap. Flow
-$442M
Cap. Flow
% of AUM
-1,013.48%
Top 10 Holdings %
Top 10 Hldgs %
28.16%
Holding
580
New
77
Increased
4
Reduced
27
Closed
472
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$1.24M |
| 2 |
TSMC
TSM
|
+$1.13M |
| 3 |
NuScale Power
SMR
|
+$1.11M |
| 4 |
Trade Desk
TTD
|
+$1.02M |
| 5 |
Microchip Technology
MCHP
|
+$910K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$5.39M |
| 2 |
Accenture
ACN
|
+$5.35M |
| 3 |
CRWV
CoreWeave
CRWV
|
+$4.97M |
| 4 |
Robinhood
HOOD
|
+$4.87M |
| 5 |
Expedia Group
EXPE
|
+$4.81M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.63% |
| 2 | Healthcare | 13.02% |
| 3 | Communication Services | 12.94% |
| 4 | Consumer Discretionary | 11.11% |
| 5 | Industrials | 9.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Hayward Holdings
HAYW
$3.28B
| – | – |
-27,600
| Closed | -$417K |
|
302
Hudbay
HBM
$9.67B
| – | – |
-26,500
| Closed | -$402K |
|
303
HEICO Corp
HEI
$50.8B
| – | – |
-3,459
| Closed | -$1.12M |
|
304
Helen of Troy
HELE
$672M
| – | – |
-8,200
| Closed | -$207K |
|
305
Hecla Mining
HL
$9.76B
| – | – |
-14,900
| Closed | -$180K |
|
306
Helios Technologies
HLIO
$2.56B
| – | – |
-8,200
| Closed | -$427K |
|
307
Hillman Solutions
HLMN
$1.6B
| – | – |
-10,600
| Closed | -$97.3K |
|
308
HNI Corp
HNI
$3.17B
| – | – |
-6,085
| Closed | -$285K |
|
309
Harley-Davidson
HOG
$2.66B
| – | – |
-40,365
| Closed | -$1.13M |
|
|
310
Robinhood
HOOD
$83.3B
| – | – |
-34,000
| Closed | -$4.87M |
|
311
Helmerich & Payne
HP
$3.31B
| – | – |
-10,400
| Closed | -$230K |
|
312
Hewlett Packard
HPE
$60.4B
| – | – |
-38,230
| Closed | -$939K |
|
313
HP
HPQ
$25.9B
| – | – |
-13,500
| Closed | -$368K |
|
314
HealthEquity
HQY
$8.46B
| – | – |
-6,300
| Closed | -$597K |
|
|
HSAI
315
Hesai Group
HSAI
$2.5B
| – | – |
-7,600
| Closed | -$214K |
|
316
Humana
HUM
$46.7B
| – | – |
-2,256
| Closed | -$587K |
|
317
Interactive Brokers
IBKR
$40.5B
| – | – |
-21,900
| Closed | -$1.51M |
|
318
ICICI Bank
IBN
$109B
| – | – |
-7,329
| Closed | -$222K |
|
319
Icon
ICLR
$13.9B
| – | – |
-1,600
| Closed | -$280K |
|
320
Idexx Laboratories
IDXX
$44.9B
| – | – |
-7,200
| Closed | -$4.6M |
|
321
International Flavors & Fragrances
IFF
$20.2B
| – | – |
-19,861
| Closed | -$1.22M |
|
322
InterContinental Hotels
IHG
$23.9B
| – | – |
-2,316
| Closed | -$281K |
|
323
Immunovant
IMVT
$7.99B
| – | – |
-12,976
| Closed | -$209K |
|
324
Indivior Pharmaceuticals
INDV
$4.85B
| – | – |
-9,700
| Closed | -$234K |
|
325
Inter&Co
INTR
$2.47B
| – | – |
-18,400
| Closed | -$170K |
|
Similar funds
KL
FWS
FRIHG
AGFVA
1C
MP
FLC
APW
Bayesian Capital Management's Q4 2025 Portfolio in Review
As of Q4 2025, Bayesian Capital Management held 580 positions worth $43.6M, down 91% from $490M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Bayesian Capital Management withdrew a net $442M in Q4 2025, closing 472 positions and reducing 27 holdings. Its most notable exit was Boston Scientific, an estimated $5.39M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Communication Services.
Against the trend, Bayesian Capital Management opened a new position in JPMorgan Chase worth $1.29M.
- Bayesian Capital Management's largest Q4 2025 buy was JPMorgan Chase: 4,000 shares worth $1.29M.
- Bayesian Capital Management added most to TSMC in Q4 2025, an estimated $1.13M increase.
- Bayesian Capital Management's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $4.54M.
- Bayesian Capital Management fully exited Boston Scientific in Q4 2025, selling an estimated $5.39M.
- Bayesian Capital Management's ten largest holdings make up 28% of its $43.6M portfolio in Q4 2025.
- Bayesian Capital Management opened 77 new positions and closed 472 in Q4 2025.
- Bayesian Capital Management's portfolio value fell 91% quarter-over-quarter to $43.6M.
Based on Bayesian Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.